According to the International Classification of Sleep Disorders (Third Edition), Insomnia is defined as: either trouble initiating or maintaining sleep, associated with daytime consequences, and…
On Jan 10, 2022, FDA has approved this new medication for treatment of adults with insomnia: Quviviq (daridorexant). This FDA approval is based on the…
On Dec 23, 2019 Eisai Inc. announced the FDA approval of DAYVIGO™ (Lemborexant) for insomnia management. This post will summarize the important clinically relevant facts…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
